Efficient AI-Driven Multi-Section Whole Slide Image Analysis for Biochemical Recurrence Prediction in Prostate Cancer

arXiv cs.CV / 3/24/2026

💬 OpinionSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper introduces an AI framework that analyzes multiple whole-slide pathology sections together to model the full tumor landscape across the entire prostate gland for biochemical recurrence (BCR) prediction after radical prostatectomy.
  • Using a large dataset of 23,451 slides from 789 patients, the model achieves strong performance for predicting 1- and 2-year BCR and outperforms established clinical benchmarks.
  • The AI-generated risk score is reported as the most powerful independent prognostic factor in multivariable Cox proportional hazards analysis, exceeding conventional markers such as pre-operative PSA and Gleason score.
  • The authors show that patch and slide sub-sampling can substantially reduce computational cost during training and inference while maintaining predictive performance, improving scalability.
  • External validation is used to support generalizability, and the results are positioned as clinically feasible for post-operative management decisions.

Abstract

Prostate cancer is one of the most frequently diagnosed malignancies in men worldwide. However, precise prediction of biochemical recurrence (BCR) after radical prostatectomy remains challenging due to the multifocality of tumors distributed throughout the prostate gland. In this paper, we propose a novel AI framework that simultaneously processes a series of multi-section pathology slides to capture the comprehensive tumor landscape across the entire prostate gland. To develop this predictive AI model, we curated a large-scale dataset of 23,451 slides from 789 patients. The proposed framework demonstrated strong predictive performance for 1- and 2-year BCR prediction, substantially outperforming established clinical benchmarks. The AI-derived risk score was validated as the most potent independent prognostic factor in a multivariable Cox proportional hazards analysis, surpassing conventional clinical markers such as pre-operative PSA and Gleason score. Furthermore, we demonstrated that integrating patch and slide sub-sampling strategies significantly reduces computational cost during both training and inference without compromising predictive performance, and generalizability of AI was confirmed through external validation. Collectively, these results highlight the clinical feasibility and prognostic value of the proposed AI-based multi-section slide analysis as a scalable tool for post-operative management in prostate cancer.